Design Considerations for Pharmaceutical Quarantine Cold Rooms

In the pharmaceutical industry, product integrity and patient safety begin with proper storage. Among the most critical aspects of storage design is the need for quarantine cold rooms—dedicated spaces where unreleased, suspect, or rejected products are held securely and separately from approved inventory.

These cold rooms are not just about temperature control. They are part of a rigorous Good Manufacturing Practice (GMP) framework that ensures no cross-contamination or mix-ups occur within the supply chain. For pharmaceutical manufacturers, distributors, and clinical supply depots in Singapore and the region, investing in the right coldroom design for quarantine storage is a non-negotiable compliance and quality priority.

This article explores key design principles for pharmaceutical quarantine cold rooms, highlighting how careful layout, containment protocols, and regulatory adherence can protect both product safety and brand reputation.

1. Isolated Cold Storage for Non-Released or Suspect Products

Quarantine cold rooms serve a specific purpose: to temporarily hold pharmaceutical goods that are either pending quality release, under investigation, or suspected of being non-compliant. These products may include:

• Batches awaiting QC testing.

   

• Returns under quality investigation.

   

• Goods involved in deviation reports.

   

• Products subject to temperature excursions during transit.

   

To maintain clear segregation, quarantine cold rooms must be physically and operationally isolated from general storage areas. Shared spaces or weak zoning can lead to mix-ups that trigger recalls, audit findings, or worse—risk to patient safety.

Design Strategies:

• Separate Access Points: Quarantine cold rooms should have their own access doors, ideally with restricted entry and clear signage such as “Quarantine Storage – No Release”.

   

• Color-Coded or Labeled Zones: Inside the coldroom, visual cues help staff identify quarantine areas and prevent unintentional access or movement.

   

• Digital Access Control: Integrating card or biometric systems ensures only authorized QA personnel can enter.

   

Example: Pharmaceutical Depot in Tuas

A cold chain distributor in Tuas handles both commercial and investigational medicinal products. Kiat Lay was engaged to retrofit a GMP-compliant quarantine chiller with an isolated entrance, floor markings, and access logs. QA staff are the only ones with entry permissions, and the storage temperature is monitored independently from the main warehouse system. This setup passed their last audit with zero findings in storage compliance.

2. Containment Design to Avoid Cross-Contamination

While most pharmaceutical coldrooms are built to prevent contamination through insulation and temperature controls, quarantine rooms require additional measures to ensure no physical, microbial, or packaging contamination occurs.

Key Containment Features:

• Smooth, Non-Porous Surfaces: Floors, walls, and ceilings should be seamless and easy to sanitize, preventing microbial buildup.

   

• Dedicated HVAC Systems or Filters: Shared airflow with general storage areas is discouraged. Use of HEPA filters or independent cooling units is preferred.

   

• Positive or Negative Pressure Zones: Depending on the type of product or contamination risk, quarantine rooms may require specific air pressure design to control airflow direction.

   

• Drainage Control: Prevent any risk of liquid flow (e.g. from condensation or defrost cycles) between adjacent coldrooms.

   

Case Study: Regional Clinical Trial Storage Hub

A regional clinical trial supply facility required a -20°C quarantine freezer for rejected investigational products. Kiat Lay provided a custom solution with sealed internal surfaces, epoxy floors with coved edges, and an independent refrigeration unit. The door frame was installed with airtight gaskets to prevent vapor exchange, and an alarm system was added to notify QA teams of any unauthorized opening. This high-spec design supported both HSA and EU GMP audit readiness.

3. Compliance with GMP and Quarantine Regulations

Designing a quarantine cold room is not only about operations—it’s about meeting the regulatory standards enforced by agencies such as Singapore’s Health Sciences Authority (HSA), the FDA, and the EMA. These guidelines emphasise traceability, segregation, and documentation.

Regulatory Considerations in Design:

• Validation-Ready Design: Coldrooms must support performance qualification (PQ) and mapping for temperature consistency.

   

• Audit Trails and Logging: Systems should automatically record door openings, temperature deviations, and access logs.

   

• Clear Labelling and Physical Demarcation: Products under quarantine should be marked with “DO NOT USE” or “UNDER INVESTIGATION” labels, reinforced by physical separation.

   

• Cleaning and Disinfection Protocols: Coldroom surfaces must support GMP-grade cleaning chemicals without degradation.

   

Example: Biologic Storage for Monoclonal Antibodies

A facility storing monoclonal antibody (mAb) products implemented a GMP audit-ready quarantine coldroom with temperature mapping certification and automatic PDF temperature logging. When a suspect shipment arrived, the lot was quarantined without disrupting other biologic inventory. This well-prepared layout enabled full documentation during a subsequent product complaint investigation and protected the company’s manufacturing license from penalty.

4. Staff Training and SOP Integration

No coldroom design is effective without properly trained personnel. Pharmaceutical coldroom operations, especially quarantine zones, must be governed by clear SOPs (Standard Operating Procedures) that cover:

• Entry and exit protocols.

   

• Handling procedures for rejected or suspect products.

   

• Cleaning schedules and logging.

   

• Incident reporting mechanisms.

   

Kiat Lay often works in coordination with pharmaceutical clients’ QA and compliance teams to ensure that the coldroom layout supports SOP implementation, including placement of logbooks, temperature display units, and sample quarantine tags.

Why Choose Kiat Lay for Pharmaceutical Coldroom Solutions?

With decades of experience serving Singapore’s pharmaceutical, biotech, and healthcare industries, Kiat Lay understands the exacting standards required for quarantine and GMP-compliant coldroom construction.

Our services include:

• Full coldroom design and installation tailored to pharma use.

   

• Multi-zone temperature controls and high-precision monitoring.

   

• Validation-ready setups for cold chain auditing.

   

• Ongoing maintenance and emergency support.

   

Whether you operate a manufacturing site, clinical depot, or cold chain warehouse, we can help you build quarantine coldrooms that are safe, auditable, and built to regulatory standards.

Conclusion

Pharmaceutical quarantine cold rooms are a vital layer in the drug safety chain. They ensure that only fully tested, approved products reach the healthcare system while suspect items are stored securely and separately. When designed correctly, they prevent errors, support audits, and uphold public health.

By focusing on:

• Physical and operational segregation,

   

• Containment and cleaning design,

   

• GMP-aligned compliance features,

   

Pharmaceutical companies and cold chain providers can maintain the integrity of their operations and build trust with regulators and patients alike.

Looking to upgrade or construct a quarantine coldroom?
Contact Kiat Lay today to explore smart, safe, and scalable solutions for your pharmaceutical facility.

Visit www.kiatlay.com.sg